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Abstract
Background: The objective of the present study was to examine the influence of adding various amounts
beetroot (Beta vulgaris) crisps on gastrointestinal function, antioxidant status and blood and liver lipid profiles in a
high fat diet-induced dyslipidaemic rat model;
Results: The intake of a dyslipidaemic diet increased the serum total cholesterol, total cholesterol-to-HDL-
cholesterol ratio, atherogenic index, hepatic total cholesterol and triacylglycerols, suppressed production of short-
chain fatty acids and decreased total antioxidant status and blood glutathione peroxidase activity. Oral
administration of all tested amounts of beetroot crisps prevented the rise in serum total cholesterol and
triacylglycerols levels. The treatment with the addition of 3% crisps also decreased hepatic total cholesterol level
and activity of AST in serum. The experimental addition of crisps likewise resulted in a tendency towards a higher
total SCFA pool and activity of glutathione peroxidase and a lower serum glucose level (p = 0.080, p = 0.061 and p
= 0.067, respectively);
Conclusions: Results of the presented study suggest that the addition of beetroot crisps could alleviate metabolic
changes in dyslipidaemic diet-administered rats.
Keywords: Beetroot, rats, dyslipidaemic diet, gastrointestinal tract, atherogenic index
Background
A Western diet heavy in meat, fried foods and refined
grains increases the risk of developing metabolic syn-
drome, heart problems, stroke and type 2 diabetes. The
link between diet and chronic disease is well documen-
ted. Heart disease, the main cause of death in Western
countries, is greatly influenced by diet, especially by the
amount and type of fat consumed. Nutritionists recom-
mend diets rich in fruits and vegetables for good health
and for reducing the risk of heart disease and some
types of cancers. The beneficial effects of fruits, vegeta-
bles and a Mediterranean diet are likely due to many
components, including fibre and micronutrients [1]. The
fundamental active agents for reducing the risk of
chronic diseases are antioxidants [2]. Over the last sev-
eral years, increasing attention has been paid to the
antioxidant activity of plant pigments such as careto-
noids, anthocyanins and, recently, the betalains [3,4].
The most heavily studied betalain is betanin aglycone,
obtained from the extract of beet juice. Beetroot is
mainly consumed as a pickled or canned preserve, a
cooked vegetable or sometimes a juice. In Poland, red
beets are popular vegetables with a per capita consump-
tion of approximately 6 kg/year. Results from several in
vitro studies have demonstrated that betalains from
beetroots possess powerful antiradical and antioxidant
activity [5-8]. In addition, a significant tumour inhibitory
effect has been shown to accompany a dietary treatment
with beetroot ingestion [9]. Lammers [10] hypothesized
that betanin is non-perturbing to cellular metabolism,
highly compatible with enzyme function and steadies
cellular metabolic function under various kinds of stress
in animal tissue. Introduction of novel products, mainly
lacto-fermented juice and crisps, has presumably con-
tributed to the recent growth in the intake of beetroot.
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correlation between fruit/vegetable intake and the risk
of cardiovascular disease, especially when the blood lipid
profile is considered [11,12].
In this study, the hypothesis that the consumption of a
diet containing beetroot crisps could beneficially affect
gastrointestinal function, antioxidant status of the body,
and blood and liver lipid profiles was verified. To test
this hypothesis, different amounts of beetroot crisps
were applied to a Western-type and a dyslipidaemic diet.
Materials and methods
Beetroot crisps were obtained from Paula Co. (Kalisz,
Poland) and contained 14.6 g of crude protein, 48.4 g of
carbohydrates and 0.4 g fat per 100 g of crisps.
The extraction, quantification and identification of
betalains from beetroot crisps is described below. About
0.10 g of pulverized red beet crisps was extracted with 1
ml of distilled water by with triplicate 60-s sonication
and 60-s vortexing. After centrifugation (13200 × g at 4°
C, 5 min), the supernatant was collected in a 5-ml flask.
These steps were repeated 5 times. Quantification of
betalains was determined by a spectrophotometric
method according to the modified method of Stintzing
[13]. Briefly, before analysis aliquots of red beet crisps
extract was centrifuged (8400 × g, 5 min). Next, the
sample was dissolved in McIlvaine buffer (pH 6.5) to
obtain an absorbance (A) of 0.8 ≤ A ≤ 1.0. The betacya-
nins and betaxanthins contents were calculated as beta-
nin-equivalents and vulgaxanthin-equivalents,
respectively, using the following formula: [mg/g dry
matter] = (A*R*MW*V*1000)/ε*W, where “A” is the
absorption at 538 nm and 480 nm for betacyanins and
betaxanthins, respectively, “R” is the dilution factor, “V”
is the volume of extract (L), “W” is the sample weight
(g), MW is the molecular weight (550 g/mol for betanin,
339 g/mol for vulgaxanthin) and “ε” is the molar extinc-
tion coefficients (60000 L/mol*cm at l = 538 nm for
betanin, 48000 L/mol*cm at l = 480 nm for vulgax-
anthin). Chromatographic determination of betalains
were done on a Shimadzu HPLC system (Kyoto, Japan)
consisting of two pumps (LC-10ADVP), a DAD detector
(SPD-M10 AVP) set at 538 nm and 480 nm, a MS detec-
tor (QP8000a), an autosampler (SIL-10 ADVP) set to 10
μLi n j e c t i o n ,ac o l u m no v e n( C T O - 1 0A S VP)a n das y s -
tem controller (SCL-10 AVP). Before HPLC injection,
the extracts were centrifuged (20 min, 13200 × g). All
chromatographic determinations were performed at 25°
C with the flow rate of 0.2 mL/min on C-18 BDS
Hypersile-Keystone 3 μ 100 × 4 mm column (Thermo,
Waltham USA). The elution was done using a solvent
gradient system consisting of solvent A (0.1% formic
acid aqueous solution) and solvent B (0.1% formic acid
acetonitrile solution). Gradients were as follows: 2-17-
80-80-2-2% B at gradient times, tG = 0-35-36-42-43-60
min. Betalains were identified based on the UV-visible
spectrum, the presence of the respective ion (m/z
values) and previously published data [13-15]. The mass
spectrometer with electrospray ionization (ESI) worked
in the positive mode with the following parameters:
CDL temperature of 260°C, CDL voltage of 70V, probe
voltage of 4.5 kV, nebulizer gas (N2) flow of 4.5 L/min,
and defragmentation voltage of 50 V. All determinations
were performed in triplicate. The use of animals was
conducted in compliance with European guidelines for
the care and use of laboratory animals and was
approved by the Ethical Committee for Animal Experi-
ments in the northeastern region of Poland. The experi-
ment was performed on 64 male Wistar rats aged
approximately 4 weeks (body weight 103.8 ± 3.92 g).
The experimental diets were administered for 4 weeks
to 8 rats per group housed individually in Plexiglass
cages. The prevailing environmental temperature was
21-22°C, relative humidity of 50-70% with a 12 h light-
dark cycle and intensive ventilation of rooms (15×/h).
The animals were allowed access to experimental diets
and water ad libitum. The composition of the experi-
m e n t a ld i e t si ss h o w ni nT a b l e1 .A l ld i e t sc o n t a i n e d
14.8% casein, 5% cellulose, 0.2% DL-methionine and
0.2% vitamin-mineral mixture AIN-93G [16]. The stan-
dard basal diet containing 8% soybean oil and 0.3% cho-
lesterol was supplemented with different amounts of
beetroot crisps: 0, 0.3, 1 or 3%. The dyslipidaemic basal
diet was prepared with the aid of lard instead of oil, an
extended amount of cholesterol - 1%, and 0.5% cholic
acid, and was supplemented with the same amounts of
crisps.
At the end of the feeding experiment, the experimen-
tal animals were anaesthetized with sodium pentobarbi-
tone, blood was taken from the caval tail vein, and
serum was then obtained after clotting. The
Table 1 Composition of experimental diets, %
B0 B0.3 B1 B3
SDSDSDSD
Casein 14.8 14.8 14.8 14.8 14.8 14.8 14.8 14.8
DL-methionine 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2
Cellulose 5 5 5 5 5 5 5 5
Beetroot crisps - - 0.3 0.3 1 1 3 3
Soybean oil 8 - 8 - 8 - 8 -
Lard - 8 - 8 - 8 - 8
Cholic acid - 0.5 - 0.5 - 0.5 - 0.5
Cholesterol 0.3 1 0.3 1 0.3 1 0.3 1
Mineral mix
1 33333333
Vitamin mix
1 22222222
Maize starch 66.7 65.5 66.4 65.2 65.7 64.5 63.7 62.5
1According to Reeves (1997)
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Page 2 of 8gastrointestinal tract was excised immediately and
weighed. The pH of in the contents of the stomach,
small intestine, caecum and colon was measured using a
microelectrode and a pH/ION meter (model 301, Hanna
Instruments). Samples of fresh digestive tract contents
were used for immediate analysis (dry matter content
and ammonia); the rest was transferred to tubes and
stored at -40°C. Dry matter of the digesta was deter-
mined at 105°C. Ammonia extracted and trapped in a
solution of boric acid in Conway dishes was determined
by direct titration with sulphuric acid [17]. Glycolytic
activity in the caecal digesta was measured by the rate
of release of p-o ro-nitrophenol from their nitrophenyl-
glucosides according to the modified method of Djouzi
and Andrieux [18] described by Juśkiewicz and co-work-
ers [19]. The following substrates were used: p-nitrophe-
nyl-b-D-glucuronide for b-glucuronidase and p-
nitrophenyl-b-D-glucopyranoside for b-glucosidase. The
reaction mixture contained 0.3 ml of substrate solution
(5 mM) and 0.2 ml of a 1:10 (v/v) dilution of the caecal
sample in 100 mM phosphate buffer (pH 7.0) after cen-
trifugation at 10,000 × g for 15 min. Incubations were
c a r r i e do u ta t3 7 ° Cf o r1 0m i n ,a n dp-nitrophenol was
quantified at 400 nm after the addition of 2.5 ml of 0.25
M cold sodium carbonate. Enzymatic activity (b-glucosi-
dase and b-glucuronidase) was expressed as μmol pro-
duct formed per min (IU) per g digesta in the caecal
sample. The concentration of short-chain fatty acids
(SCFA) was analysed by gas chromatography: Shimadzu
GC-14A with a glass column 2.5 m × 2.6 mm, contain-
ing 10% SP-1200/1% H3PO4 on 80/100 Chromosorb W
AW with column temperature 110°C, detector FID tem-
perature 180°C, injector temperature 195°C. The caecal
digesta were weighed (sample of about 0.2 g), mixed
with 0.2 ml of formic acid, diluted with deionised water
and centrifuged at 10,000 × g for 5 min [20]. The super-
natant was decanted for injection into the gas chromato-
graph. Diagnostic kits (Alpha Diagnostics, Poland) were
used for determination of the concentration of glucose,
cholesterol (total and HDL), triglycerides and activity of
alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) in the serum. HDL cholesterol was
measured after selective precipitation of low and very
low-density serum lipoproteins with polypropylene gly-
col (PEG-600) and further removal by centrifugation.
The atherogenic index was calculated using the formula:
atherogenic index = TC-HDL/HDL described by Aziz
[21]. Superoxide dismutase (EC 1.1.5.1; SOD) and glu-
tathione peroxidase (EC 1.11.1.9; GPx) activities in ery-
throcyte lysates and total antioxidant status (TAS) were
assayed using kits from Randox Laboratories Ltd.
(Crumlin, United Kingdom). The principle of the TAS
assay is the incubation of ABTS with peroxidase (met-
myoglobin), which results in the production of a radical
cation. This species is a blue-green colour and can be
detected at 600 nm. In the added sample, the antioxi-
dants suppress the production of this colour proportion-
ally to their concentration.
Total hepatic cholesterol and triglycerides were mea-
sured in kidneys and liver using standard diagnostic kits
(Alpha Diagnostics, Poland) after lipid extraction by the
Folch method.
Statistical analysis
All data were analyzed using two-way ANOVA with the
aid of Statistica 6.0 for Windows (StatSoft Corp, Kra-
kow, Poland). Data are expressed as means. Multiple
comparisons of the means were performed using the
Duncan Multiple Range Test at a 5% probability.
Results
Betalains analysis in red beet crisps showed that beta-
cyanins content was 4.10 ± 0.05 mg/g of the dry matter,
whereas betaxanthin content was 2.80 ± 0.07 mg/g of
the dry matter. Betacyanins were present as betanin
(57%), isobetanin (35%) and neobetanin (1.4%). In the
case of betaxanthins, the predominant compound was
vulgaxanthin (70%).
After the experimental period (4 weeks), final body
weight (BW) of the rats fed standard diets were higher
as compared to those fed dyslipidaemic diets (267.1 vs.
248.8 g, p < 0.05), whereas the experimental dietary
application of the crisps did not affect the final BW of
the animals (Table 2). The type of diet significantly
affected the pH value in the stomach, ileum and caecum
(dyslipidaemic > standard, p < 0.05). The highest dietary
addition of beetroot crisps (3% of a diet) caused a signif-
icant alkalization of ileal digesta as compared to other
treatments. Rats fed dyslipidaemic diets were character-
ized by decreased bulk and dry matter concentrations in
the caecal contents as well as elevated concentrations of
caecal ammonia (p < 0.05 vs. standard diet). When the
application of beetroot crisps is considered, the highest
and the lowest caecal dry matter concentrations were
observed in the B0 and B3 treatments (p <0 . 0 5v s .B 1,
B3 and p < 0.05 vs. B0,B 0.3, respectively). The activity of
bacterial b-glucosidase and b-glucuronidase was signifi-
cantly diminished in the caecum of dyslipidaemic rats.
In the present investigation, feeding dyslipidaemic
diets significantly lowered total SCFA as well as acetic,
propionic, butyric and valeric acid concentrations (Table
3). The supplementation of 3% beetroot crisps was
accompanied by a significant decrease in caecal isovale-
ric acid concentration in comparison to other treat-
ments (p ≤ 0.05). The dietary supplementation with 1
and 3% of beetroot crisps caused a higher acetate pro-
portion compared to the group without crisps added.
The type of diet significantly influenced the SCFA
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lower percentage of butyric acid and a higher ratio of
propionic and acetic acid in comparison to the rats fed
standard diets. In addition, two-way ANOVA revealed
that among the dyslipidaemic groups the highest dietary
addition of beetroot crisps resulted in a diminished ratio
of butyrate in the SCFA profile as compared to the B0D
group (see significant interaction C×D). The experimen-
tal addition of beetroot crisps in amounts of 0.3-3% of a
diet resulted in a significant increase in the caecal acet-
ate pool (expressed as μmol/100 g of BW) as well as a
tendency towards a higher total SCFA pool (p =0 . 0 8 0 ) .
Moreover, total and individual SCFA pools were about
twofold higher in the standard diet treatments than in
the dyslipidaemic groups (p ≤ 0.05).
The content of beetroot crisps substantially decreased
the serum triacylglycerols and total cholesterol level in
rats (p ≤ 0.05, Table 4). In the latter case, it was due to
hypocholesterolemic action of dietary crisps in the dysli-
pidaemic groups (see significant interaction C×D, p =
0.05). The highest and the lowest dietary addition of
beetroot crisps also resulted in a tendency towards
decreased serum glucose concentration and atherogenic
index value (p = 0.067 and p = 0.095, respectively). The
B3 treatment was associated with a decreased serum AST
activity in comparison to treatment B1. The treatments
with the addition of crisps tended to increase blood GPx
activity (p = 0.061). The rats fed dyslipidaemic diets were
characterized by decreased concentrations of serum tria-
cylglycerols and HDL-cholesterol, diminished TAS of the
serum and blood GPx activity as well as increased serum
level of total cholesterol, total cholesterol-to-HDL choles-
terol ratio and atherogenic index level. Dyslipidaemic rats
were also characterized by increased activities of serum
AST and ALT (p ≤ 0.05). The significant interaction
revealed that among the dyslipidaemic rats those fed 3
and 0.3% crisps-containing diets were characterized by
decreased ALT activity (p <0 . 0 5v s .B 0D, B1Da n dp <
0.05 vs. B0D group, respectively).
Dyslipidaemic diets enhanced hepatic triacylglycerols
and total cholesterol levels (Table 5). Diet supplementa-
tion with 3% beetroot crisp decreased liver cholesterol
levels in comparison to other treatments, but only when
dyslipidaemic groups are considered.
Table 2 Final body weights and parameters of gastrointestinal tract of rats fed experimental diets
Body
weight, g
pH Caecal indices Activity of bacterial
enzymes in caecal digesta
stomach ileal caecal tissue, g/100
g b.w.
digesta, g/
100 g b.w.
ammonia,
mg/100 g
dry
matter,
%
b-
Glucosidase
b-
Glucuronidase
Subgroup
B0S 265.6 3.67 6.48 6.74 0.227 0.965 3.27 24.88 0.433 0.94
B0.3S 262.8 3.68 6.55 6.71 0.239 1.099 3.15 23.54 0.490 0.87
B1S 264.8 3.61 6.48 6.92 0.231 1.073 3.55 23.17 0.380 1.10
B3S 275.3 3.54 6.85 6.85 0.239 1.085 3.07 22.00 0.393 0.87
B0D 248.1 3.89 6.70 7.11 0.238 0.706 4.35 22.25 0.059 0.36
B0.3D 245.7 3.74 6.92 7.11 0.231 0.717 4.12 22.41 0.048 0.35
B1D 250.8 4.28 6.68 7.13 0.263 0.807 4.21 20.20 0.039 0.39
B3D 250.6 4.10 6.99 7.17 0.243 0.937 3.77 18.78 0.035 0.36
SEM 2.081 0.072 0.036 0.030 0.006 0.031 0.093 0.321 0.029 0.044
Chips (C)
B0 256.9 3.78 6.59
b 6.93 0.233 0.835 3.81 23.56
a 0.246 0.65
B0.3 254.3 3.71 6.74
b 6.91 0.235 0.908 3.64 22.98
ab 0.269 0.61
B1 257.8 3.94 6.58
b 7.03 0.247 0.940 3.88 21.69
bc 0.210 0.74
B3 262.9 3.82 6.92
a 7.01 0.241 1.011 3.42 20.39
c 0.214 0.62
P value (C) 0.374 0.681 <
0.05
0.188 0.830 0.126 0.159 < 0.05 0.525 0.214
Diet (D)
Standard 267.1
a 3.62
b 6.59
b 6.81
b 0.234 1.055
a 3.26
b 23.40
a 0.424
a 0.94
a
Dyslipidemic 248.8
b 4.00
a 6.82
a 7.13
a 0.244 0.792
b 4.11
a 20.91
b 0.045
b 0.36
b
P value (D) < 0.05 < 0.05 <
0.05
< 0.05 0.402 < 0.05 < 0.05 < 0.05 < 0.05 < 0.05
P value (CxD) 0.751 0.372 0.564 0.475 0.667 0.470 0.720 0.433 0.707 0.454
abc - values within each row with the same superscript are not different at P ≤ 0.05
S-standard groups; D-dyslipidemic groups, B0 -groups without beetroot crisps, B0.3,B 1,B 3 -groups with 0.3, 1 and 3% beetroot crisps respectively
Wroblewska et al. Lipids in Health and Disease 2011, 10:178
http://www.lipidworld.com/content/10/1/178
Page 4 of 8Discussion
Consumption of beetroot and its products has many
possible health benefits, linked to a high content of
betalains. In our study, the content of beetroot crisps in
the rat diet was 0.3, 1 or 3%, which corresponds to a
daily intake of 18, 60 and 180 g beetroot crisps for adult
consumers with an average body weight of 70 kg.
In the current study, addition of beetroot crisps did
not significantly affect final body weight, but final body
weights were significantly influenced by fat type supple-
mentation. In a study by Danicke [22], feeding male
broiler chickens a diet containing tallow decreased the
final body weights of the birds. Animals fed a high beef
fat diet ate less food and developed more and larger
intestinal tumours with more metastases to the abdom-
inal cavity, lungs and liver [23]. On the other hand, in
experiment by Moundras [24], a diet modified by the
addition of 0.3% cholesterol did not significantly change
the final body weight of rats. In this study, a significant
decrease in pH of digesta in the ileum and dry matter
content in the caecum digesta, a slight increase of cae-
cum digesta mass (i.e., by about 8-21%) when compared
to the control and comparable ammonium concentra-
tions showed that diets with beetroot crisps slightly
affected indices of caecal function. In this experiment,
dylipidaemic diet treatment lowered caecal digesta
weight and enhanced the pH value in the gastrointest-
inal tract. The results of our investigation are different
from those of Moundras [24], who did not observe sig-
nificant changes in caecal pH. Addition of red beet
crisps to the diet had no influence on the activity of
bacterial enzymes in the caecum digesta, although it is
known that endogenous b-glucosidase participates in
biotransformation of polyphenolics in the alimentary
tract [25], and higher polyphenolic content may evoke
its lower activity in intestinal digesta [26]. A lower activ-
ity of microbial b-glucuronidase in the digesta is desir-
able as this enzyme participates in the activation of
many procarcinogenic compounds [27]. The dyslipidae-
mic diet significantly affected the activity of b-glucosi-
dase and b-glucuronidase, and these effects were
accompanied by a reduction of SCFA production, higher
alkalization of the digesta and lower bulk and dry matter
concentrations in the caecal contents, which may
Table 3 Short chain fatty acids concentration (SCFA), pool and profile in the caecal digesta of rats fed experimental
diets
Concentration, μmol/g Profile, μmol/100
μmol SCFA
SCFA pool, μmol/100 g bw
C2 C3 C4i C4 C5i C5 Total C2 C3 C4 C2 C3 C4i C4 C5i C5 Total
Subgroup
B0S 67.4 18.6 0.85 12.7 1.37 1.58 102.5 66 18 13
a 64.4 17.9 0.83 12.3 1.33 1.52 98.3
B0.3S 76.3 19.5 0.85 13.8 1.32 1.69 113.4 67 17 12
a 83.6 21.6 0.93 15.2 1.46 1.85 124.7
B1S 77.3 18.3 0.82 13.3 1.28 1.62 112.7 68 16 12
a 82.8 19.9 0.91 13.9 1.37 1.71 120.6
B3S 75.2 17.8 0.65 14.7 0.88 1.58 110.8 68 16 13
a 80.7 19.3 0.71 15.8 0.99 1.70 119.3
B0D 53.5 15.08 0.93 6.70 1.27 0.78 78.22 68 19 9
b 39.3 11.3 0.67 5.0 0.92 0.55 57.7
B0.3D 59.6 16.29 0.89 6.95 1.33 1.03 86.14 69 19 8
bc 42.2 11.5 0.62 4.8 0.89 0.71 60.70
B1D 56.5 15.10 0.73 6.60 1.09 0.97 81.01 70 19 8
bc 46.2 12.2 0.61 5.3 0.88 0.79 66.0
B3D 56.05 13.94 0.65 5.60 0.88 0.81 77.92 72 18 7
c 50.7 13.0 0.59 5.0 0.81 0.78 70.9
SEM 1.695 0.391 0.037 0.501 0.050 0.057 2.474 0.364 0.262 0.330 2.798 0.734 0.042 0.651 0.053 0.074 4.192
Chips (C)
B0 60.4 16.9 0.89 9.7 1.32
a 1.18 90.37 67
b 19 11 51.9
b 14.6 0.75 8.6 1.12 1.04 78.0
B0.3 68.0 17.9 0.87 10.3 1.33
a 1.36 99.78 68
ab 18 10 62.9
a 16.6 0.78 10.0 1.17 1.28 92.7
B1 66.9 16.7 0.77 10.0 1.19
a 1.29 96.84 69
a 17 10 64.5
a 16.0 0.76 9.6 1.13 1.25 93.3
B3 65.6 15.9 0.65 10.2 0.88
b 1.19 94.38 70
a 17 10 65.7
a 16.2 0.65 10.4 0.90 1.24 95.1
P value (C) 0.180 0.197 0.093 0.735 <
0.05
0.222 0.256 <
0.05
0.076 0.738 <
0.05
0.633 0.691 0.131 0.164 0.126 0.080
Diet (D)
Standard 74.0
a 18.6
a 0.79 13.6
a 1.21 1.62
a 109.9
a 67
b 17
b 12
a 77.9
a 19.7
a 0.85
a 14.3
a 1.29
a 1.69
a 115.7
a
Dyslipidemic 56.4
b 15.1
b 0.80 6.5
b 1.14 0.90
b 80.8
b 70
a 19
a 8
b 44.6
b 12.0
b 0.62
b 5.0
b 0.87
b 0.71
b 63.8
b
P value (D) <
0.05
<
0.05
0.906 <
0.05
0.457 <
0.05
<
0.05
<
0.05
<
0.05
<
0.05
<
0.05
<
0.05
<
0.05
<
0.05
<
0.05
<
0.05
<0.05
P value (CxD) 0.794 0.982 0.874 0.062 0.852 0.818 0.792 0.458 0.805 <
0.05
0.385 0.628 0.810 0.102 0.478 0.727 0.433
abc - values within each row with the same superscript are not different at P ≤ 0.05
S-standard groups; D-dyslipidemic groups, B0 -groups without beetroot crisps, B0.3,B 1,B 3 -groups with 0.3, 1 and 3% beetroot crisps respectively
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Concentration Activity of enzymes
Glucose,
mmol/L
Triacylglyceroles,
mmol/L
Total Cholesterol,
mmol/L
HDL Cholesterol,
mmol/L
Total Cholesterol/HDL
Cholesterol
Atherogenic
index
Total Antioxidant
Status, mmol/L
ALT,
U/L
AST,
U/L
GPx,
U/mL
SOD,
U/mL
Subgroup
B0S 15.12 2.64 2.77
c 1.31 2.20 1.20 0.952 28
d 110 31388 276
B0.3S 14.61 1.95 2.46
c 1.30 1.93 0.93 0.921 37
d 110 33193 281
B1S 14.13 2.10 2.62
c 1.28 2.08 1.08 0.924 37
d 111 34946 289
B3S 13.37 2.19 2.64
c 1.32 2.04 1.04 0.954 37
d 109 33309 287
B0D 15.39 0.91 12.70
a 0.84 15.41 14.41 0.816 62
a 161 27605 278
B0.3D 13.49 0.91 10.24
b 1.01 10.99 9.99 0.836 55
bc 162 30662 272
B1D 14.11 0.80 10.27
b 0.78 13.29 12.29 0.900 57
ab 171 30707 272
B3D 13.08 1.02 10.22
b 0.86 12.69 11.69 0.871 49
c 142 30078 270
SEM 0.263 0.096 0.555 0.038 0.779 0.779 0.009 1.614 3.718 489.44 3.528
Chips (C)
B0 15.26 1.77
a 7.74
a 1.07 8.80 7.80 0.884 45 136
ab 29496 277
B0.3 14.05 1.43
b 6.35
b 1.15 6.46 5.46 0.879 46 136
ab 31927 277
B1 14.12 1.45
b 6.44
b 1.03 7.69 6.69 0.912 47 141
a 32826 281
B3 13.22 1.61
b 6.43
b 1.09 7.37 6.37 0.912 43 125
b 31693 279
P value (C) 0.067 < 0.05 < 0.05 0.402 0.105 0.105 0.198 0.283 < 0.05 0.061 0.979
Diet (D)
Standard 14.31 2.22
a 2.62
b 1.30
a 2.06
b 1.06
b 0.938
a 35
b 110
b 33209
a 283
Dyslipidemic 14.02 0.91
b 10.86
a 0.87
b 13.10
a 12.10
a 0.856
b 56
a 159
a 29763
b 273
P value (D) 0.579 < 0.05 < 0.05 < 0.05 < 0.05 < 0.05 < 0.05 < 0.05 < 0.05 < 0.05 0.160
P value (CxD) 0.808 0.077 0.050 0.435 0.179 0.179 0.067 < 0.05 0.092 0.906 0.785
abc - values within each row with the same superscript are not different at P ≤ 0.05
Atherogenic index was calculated as fallow TC-HDL/HDL
S-standard groups; D-dyslipidemic groups, B0 -groups without beetroot crisps, B0.3,B 1,B 3 -groups with 0.3, 1 and 3% beetroot crisps respectively
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testinal tract.
Our results showed that the supplementation of diets
with beetroot crisps marginally enhanced the total SCFA
pool compared to the control group pool but did not affect
the caecal pH. This study identified unwanted changes of
SCFA concentration under the influence of lard and cho-
lesterol addition to the diet. The dyslipidaemic diet
decreased the ratio of butyric acid in the SCFA profile and
increased the acetic and propionic ratios. The addition of
lard and cholesterol to the diet decreased the SCFA pool
compared to the control groups, but this effect was not
observed by Moundras [24]. It is well known that SCFAs
are the main product of bacterial fermentation in the large
intestine of animals and humans. All SCFAs are rapidly
absorbed from the hindgut and stimulate water and salt
absorption. SCFAs play an important role in the function
of the large bowel as an energy source for the colonic
epithelium. Butyrate, which regulates epithelial cell growth,
is especially important for health of the large bowel [28].
In the reported study, diet supplementation with 0.3
and 1% crisps decreased the triacylglycerol level by
about 20%. Glucose level was similarly affected by tea
catechins in the experiment by Kao and co-authors [29]
conducted with Sprague-Dawley rats and 5-month-old
mice with 1% tea catechin [30]. In this work, the appli-
cation of a dyslipidaemic diet led to the deterioration of
the biochemical indices of serum in rats, reflected in an
enhanced total cholesterol level (4 fold) and higher
activity of transaminases and at the same time lower
HDL cholesterol level. Moundras [24] observed an
increase in total cholesterol level in a group of rats fed a
diet with cholesterol and significantly higher serum tri-
glyceride concentrations. Mandukhail also showed that a
dyslipidaemic diet increased serum total cholesterol,
total cholesterol-to-HDL-cholesterol ratio and athero-
genic index [31]. High fat treatment resulted in oxida-
tive stress in rats thus enhanced oxidation of low-
density lipoprotein, which plays a key role in the genesis
of atherosclerosis. Antioxidants such as betalains are
known to efficiently protect against this kind of damage
[32]. In our study, we did not observe significant
changes in the activity of transaminase in animals fed
diets with beetroot crisps in comparison to the control
groups. Mekkawy [33] observed its increase in a 30-day
experiment with rats fed synthetic and natural dyes, as
well as beet red-supplemented diet (0.08 and 0.4 g/kg
diet). From the present results, we did not observe a
higher antioxidant activity of diets containing beetroot
crisps; neither the activity of SOD and GPx enzymes
nor the total antioxidant status was significantly chan-
ged compared to the control group. Nevertheless, many
in vitro studies with betalains from red beets have
demonstrated that they possess high antiradical and
antioxidant activity [5,7,13,34]. Lu and co-authors [35]
found that the oral administration of betalains from red
beets (5, 20 or 80 mg/kg BW) in irradiated mice signifi-
cantly enhanced the activity of SOD and GPx in the
liver, spleen and kidney in a dose-dependent manner. In
three different experimental tumour models in mice,
Kapadia [36] reported that a very low dose of betanin
(0.0025%) from beetroot acts as a potent chemopreven-
tive agent.
From the present study, it becomes clear that feeding
of the 3% beetroot crisps-supplemented diet decreased
hepatic total cholesterol of rats. The dyslipidaemic diet
elicited a substantial accumulation of total cholesterol
level in the liver and increased hepatic triglycerides con-
centration. In the experiment Moundras [24] a similar
tendency has been reported.
Conclusions
In conclusion, our current study demonstrates that beet-
root crisp is a healthy food due to the diminution on
total serum cholesterol and triacylglycerols levels in rats
fed dyslipidaemic diets. Beetroot crisps seems clearly to
modify caecum activity in rats fed experimental diets,
altering intensification of the ceacum fermentation of
rats and have a tendency to reduce blood glucose. It
Table 5 Concentration of hepatic cholesterol and
triacylglyceroles of rats fed experimental diets
Liver
Triacylglyceroles, mg/g Total Cholesterol, mg/g
Subgroup
B0S 10.63 7.43
c
B0.3S 11.76 8.81
c
B1S 9.53 7.29
c
B3S 9.23 6.99
c
B0D 16.69 29.49
a
B0.3D 15.23 30.43
a
B1D 13.23 29.62
a
B3D 13.14 23.65
b
SEM 0.617 1.364
Chips (C)
B0 13.66 18.46
a
B0.3 13.49 19.62
a
B1 11.38 18.45
a
B3 11.19 15.32
b
P value (C) 0.256 < 0.05
Diet (D)
Standard 10.29
b 7.63
b
Dyslipidemic 14.57
a 28.30
a
P value (D) < 0.05 < 0.05
P value (CxD) 0.843 < 0.05
abc - values within each row with the same superscript are not different at P ≤
0.05
Wroblewska et al. Lipids in Health and Disease 2011, 10:178
http://www.lipidworld.com/content/10/1/178
Page 7 of 8appears that the beetroot crisps should be consumed
more often because of its health-promoting properties.
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